Bank of America Corp DE Lowers Holdings in iShares Biotechnology ETF $IBB

Bank of America Corp DE lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,893,841 shares of the financial services provider’s stock after selling 243,108 shares during the quarter. Bank of America Corp DE owned approximately 13.40% of iShares Biotechnology ETF worth $850,894,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,000. Financial Gravity Companies Inc. bought a new stake in shares of iShares Biotechnology ETF in the second quarter valued at about $29,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $36,000. Bronte Capital Management Pty Ltd. lifted its stake in iShares Biotechnology ETF by 12.6% in the second quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock worth $37,000 after acquiring an additional 32,947 shares during the period. Finally, Parkside Financial Bank & Trust lifted its stake in iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.0%

Shares of iShares Biotechnology ETF stock opened at $167.14 on Tuesday. The firm’s 50-day moving average is $172.68 and its two-hundred day moving average is $162.92. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.